• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Securities Fraud Investigation Into Jasper Therapeutics, Inc. (JSPR) Announced – Investors Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz

By: The Law Offices of Frank R. Cruz via Business Wire
September 22, 2025 at 16:08 PM EDT

The Law Offices of Frank R. Cruz announces an investigation of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON JASPER THERAPEUTICS, INC. (JSPR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On July 7, 2025, Jasper released an update on its Phase 1b/2a clinical study of subcutaneous briquilimab for the treatment of Chronic Spontaneous Urticaria (“CSU”), referred to as the “BEACON Study,” stating that certain results “appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question,” and that Jasper was “taking steps to ensure that drug product from the lot in question is returned to the Company and that sites have drug product from other lots to continue dosing.” Further, the Company revealed it “has also determined that the drug product lot in question was used to treat participants enrolled in the ETESIAN [Study]. As a result, and in order to focus resources on advancing briquilimab in CSU, the Company is halting the study and pausing development in asthma.” Jasper also disclosed that it would be “halting development in SCID” and “will be implementing a number of other cost cutting measures including a potential restructuring, to extend runway and reduce expenses.”

On this news, Jasper’s stock price fell $3.73, or 55.1%, to close at $3.04 per share on July 7, 2025, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Jasper securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz,

2121 Avenue of the Stars, Suite 800,

Century City, California 90067

Call us at: 310-914-5007

Email us at: info@frankcruzlaw.com

Visit our website at: www.frankcruzlaw.com.

Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250922507417/en/

Contacts

Contact Us:

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz

310-914-5007

fcruz@frankcruzlaw.com

www.frankcruzlaw.com

More News

View More
After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
Today 19:20 EDT
Via MarketBeat
Topics Government
Tickers GOOGL META ORCL
Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
Today 18:25 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers GOOGL
Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Today 17:23 EDT
Via MarketBeat
Topics ETFs World Trade
Tickers FTXR JBHT RXO SAIA
QURE: Why Analysts See Up to 63% Upside After 250% Single-Day Pop
Today 16:14 EDT
Via MarketBeat
Tickers QURE
Robinhood Up 12%—Could Prediction Markets Be Its Secret Weapon?
Today 15:02 EDT
Via MarketBeat
Topics Earnings
Tickers DKNG FLUT HOOD
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.45
+0.02 (0.01%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap